Literature DB >> 4124154

Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins.

E H Beachey, M Cunningham.   

Abstract

Purified M protein of group A streptococci inhibits in vitro phagocytosis of bacteria nonspecifically when it is mixed directly with the test blood. We devised a method of preopsonization inhibition that avoids direct contact between the test blood and the opsonic inhibitory agent. Each of the M proteins tested by this method inhibited opsonization and phagocytosis of only homologous-type streptococci. Titration of the M antigen in various purified preparations demonstrated a clear dissociation between titers of type-specific precipitating M antigen and type-specific opsonic inhibitory M antigen. Since opsonization reflects protective antibody, assays of M protein based on reaction with opsonic antibody should reflect more accurately the presence of the type-specific M determinant involved in protective immunity against streptococcal infections.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4124154      PMCID: PMC422803          DOI: 10.1128/iai.8.1.19-24.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  THE PRESENCE OF A VIRULENCE FACTOR IN M PROTEIN EXTRACTS OF GROUP A STREPTOCOCCI. I. THE ENHANCEMENT OF VIRULENCE OF HOMOLOGOUS STREPTOCOCCI BY THESE EXTRACTS.

Authors:  R I KRASNER; G YOUNG; R HEITMANN
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

2.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

3.  The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man.

Authors:  E H Beachey; G H Stollerman
Journal:  Trans Assoc Am Physicians       Date:  1972

4.  The presence of a virulence factor in group A streptococcal acid extracts. 2. The enhancement of virulence of heterologous streptococci and other organisms by these extracts.

Authors:  R I Krasner; R Heitmann
Journal:  J Infect Dis       Date:  1968-02       Impact factor: 5.226

5.  New observations on the structure and antigenicity of the M proteins of the group A streptococcus.

Authors:  E N Fox; M K Wittner
Journal:  Immunochemistry       Date:  1969-01

6.  Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man.

Authors:  E H Beachey; H Alberti; G H Stollerman
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

7.  Opsonic capacity of type specific streptococcal antibodies.

Authors:  I Ofek; S Bergner-Rabinowitz; A M Davies
Journal:  Isr J Med Sci       Date:  1969 May-Jun

8.  Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test.

Authors:  R D EKSTEDT; G H STOLLERMAN
Journal:  J Exp Med       Date:  1960-10-01       Impact factor: 14.307

9.  Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood.

Authors:  E H Beachey; G H Stollerman
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

10.  Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction.

Authors:  G H STOLLERMAN; R EKSTEDT
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

  10 in total
  17 in total

1.  Conservation of protective and nonprotective epitopes in M proteins of group A streptococci.

Authors:  L Miller; V Burdett; T P Poirier; L D Gray; E H Beachey; M A Kehoe
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

2.  Repeating covalent structure of streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Purification and immunobiological properties of R antigen and its relation to M protein of type 3 group A Streptococcus.

Authors:  R H Johnson; E H Beachey
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens.

Authors:  M W Cunningham; K Krisher; D C Graves
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

5.  Guanidine extraction of streptococcal M protein.

Authors:  H Russell; R R Facklam
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin.

Authors:  E H Beachey; G L Campbell; I Ofek
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

7.  Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells.

Authors:  M Alkan; I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

8.  Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts.

Authors:  M W Cunningham; E H Beachey
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

9.  Evaluation of micro complement fixation tests for antibodies against group A streptococcal M and M-associated antigens in rabbit and human sera.

Authors:  E H Beachey; I Ofek; M Cunningham; A Bisno
Journal:  Appl Microbiol       Date:  1974-01

10.  Cloning and genetic analysis of serotype 5 M protein determinant of group A streptococci: evidence for multiple copies of the M5 determinant in the Streptococcus pyogenes genome.

Authors:  M A Kehoe; T P Poirier; E H Beachey; K N Timmis
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.